Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Japan Becomes First Country to Approve Regeneron Antibody Cocktail (casirivimab and imdevimab) for the Treatment of Mild to Moderate COVID-19

prnewswireJuly 21, 2021

Tag: Regeneron , casirivimab , COVID-19 , imdevimab

PharmaSources Customer Service